Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
about
"You Shall Not Pass"-tight junctions of the blood brain barrierCell array-based intracellular localization screening reveals novel functional features of human chromosome 21 proteinsImmune responses at brain barriers and implications for brain development and neurological function in later lifeDifferential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brainPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeDuctal barriers in mammary epitheliumEnlargement of cerebral ventricles as an early indicator of encephalomyelitisDistinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a ChipDiversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsetsBlood brain barrier: a challenge for effectual therapy of brain tumorsBrain barriers: Crosstalk between complex tight junctions and adherens junctionsTissue-specific expression of the tight junction proteins claudins and occludin in the rat salivary glandsClaudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitisTherapeutic strategies to improve drug delivery across the blood-brain barrier.Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium.Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein.Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cellsLeukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling.Dissecting gene expression at the blood-brain barrierMagnetic resonance imaging to assess blood-brain barrier damage in murine trypanosomiasis.Claudins and the modulation of tight junction permeability.Lipopolysaccharide disrupts the milk-blood barrier by modulating claudins in mammary alveolar tight junctions.Selective targeting of brain tumors with gold nanoparticle-induced radiosensitizationModulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidElucidating the principles of the molecular organization of heteropolymeric tight junction strands.Sertoli cell-specific deletion of the androgen receptor compromises testicular immune privilege in mice.Mechanisms of dendritic cell trafficking across the blood-brain barrier.Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.Development of the endothelium: an emphasis on heterogeneityThe human urothelial tight junction: claudin 3 and the ZO-1α(+) switch.Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesionsEndothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression.Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.Ontogeny of tight junction protein expression in the ovine cerebral cortex during development.Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations.Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier.Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
P2860
Q21129349-B1B8D68F-D93C-4DAC-BAF5-24E0B334F25FQ21266589-9F1674BF-09CC-47B2-86DD-A4C16BC437C0Q21558388-06ABFFA5-179D-4F35-91A6-502DD76E2CD5Q24628554-0C8CB966-72C4-49E8-A0DB-00CF91F1F8B9Q26778701-44D6D13E-F305-49F5-A6B3-7F82D269F17AQ26864317-7FAEFA06-389F-4155-BED9-FBA4A4C992FCQ27023960-ADB7454B-105B-4520-A618-29899BDB11E3Q27308739-8631EDDB-CB28-4E02-91CC-046525DE46E6Q27319805-84D9BB54-993E-4BD8-9AF2-F4E7A9E29ECCQ27334435-0DC1E6E4-9912-4195-841A-5CA32C526376Q28081947-F66486A4-BE32-4E69-868E-20C5321DE03FQ28083498-64154F58-7F9A-461C-888D-E1FF477FD026Q28581494-D78EFCFB-376A-4F6B-9FC6-36D42F8405E0Q28588370-D9AE0C42-1DE8-47A1-9C63-CC869999CD36Q30407443-82827B32-F31D-46C5-8035-25D832B7077FQ30488665-35E98E33-9CE6-45CD-949C-23F5877AF0B8Q30836300-22904062-BA9E-4A20-A9F2-353B9B61E538Q33818143-949B5F9E-3546-4DA6-95CE-41DD4757ED51Q34041547-00E733B1-9B67-43DE-AE70-0D93A8A96B10Q34462541-738BBAF5-50F2-4017-94BC-31C981E59B7CQ34531379-FFA1DD5F-C043-4EF9-A3B1-479ED508A0CEQ34650517-91690320-E9A2-4F4F-875D-CBBF5F185191Q34692863-6FB6DD7E-7F4A-4298-B65C-0D273765F025Q34701455-992F9E6A-A9E1-4825-A3A7-7055B7E49C86Q34741796-A66C1C28-DEA8-474D-885D-862D93CB530CQ34786475-F1B3EBEE-EECA-40C8-B2E6-DFA54F5B0489Q35107926-6BAB9D93-5625-450A-8557-379F774D0C4EQ35124060-E45F850E-977C-4897-9022-3FC22769A7F0Q35748581-6FEE63ED-14E8-40F9-AB8E-E3F8C7686426Q35855634-6ED400F1-6A0E-4B0E-89AD-97E11D771B64Q35893734-1A832B67-8393-4322-960D-D6CD59AC0245Q35933212-A6924A08-C5CD-4526-9ADA-A0F6E9BD35B0Q36068294-1ACAE120-8F4E-418F-AF0D-EF1925F08BD2Q36186755-062C12DE-AE92-4AB8-BD16-48FEC92EB98EQ36193529-028E0069-C441-4706-A0D2-ACAFC0A9B3EFQ36202958-AC1AE511-50C7-4BDF-9222-D18012EAF80CQ36248862-695CFB7A-39FB-4EB4-9BBF-F53CC9CDD503Q36263489-DDEAEAD2-7181-4149-82B8-7B0F839D2BBBQ36353414-88799E7C-723F-4C3B-B88D-E8E91FC29D3EQ36560327-AF6F5EB4-061A-4301-8D29-59A7DDFFF671
P2860
Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Localization of claudin-3 in t ...... human glioblastoma multiforme.
@en
Localization of claudin-3 in t ...... human glioblastoma multiforme.
@nl
type
label
Localization of claudin-3 in t ...... human glioblastoma multiforme.
@en
Localization of claudin-3 in t ...... human glioblastoma multiforme.
@nl
prefLabel
Localization of claudin-3 in t ...... human glioblastoma multiforme.
@en
Localization of claudin-3 in t ...... human glioblastoma multiforme.
@nl
P2093
P921
P1476
Localization of claudin-3 in t ...... human glioblastoma multiforme.
@en
P2093
Britta Engelhardt
Ernst-H Grote
Frank Duffner
Gesa Rascher-Eggstein
Hartwig Wolburg
Jörg Kraus
Karen Wolburg-Buchholz
Stefan Hamm
Stefan Liebner
Werner Risau
P2888
P304
P356
10.1007/S00401-003-0688-Z
P577
2003-02-25T00:00:00Z